Auna

AUNA

Market cap $471M

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA), a public limited liability company (société anonyme) incorporated and existing under the laws of Luxembourg, having its registered office at 6, rue Jean Monnet, L-2180 Luxembourg, and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B267590 (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the c.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, today announced the expansion of its insurance network in Mexico, significantly broadening its national footprint, as well as its intent to meet with debt and equity investors. Through partnerships with leading healthcare institutions, including Médica Sur in Mexico City, San Javier in Guadalajara, Simnsa in Tijuana, Centros Méd.

Auna S.A. (NYSE:AUNA ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Ana Maria Mora - Head of Investor Relations Gisele Remy Ferrero - CFO & Executive VP Jesús Antonio Zamora Leon - President, CEO & Executive Chairman of the Board Conference Call Participants Artur do Amaral Alves - Morgan Stanley, Research Division Leandro Bastos - Citigroup Inc., Research Division Operator Good morning, and welcome to Auna's Second Quarter 2025 Earnings Conference Call. My name is Ellie, and I will be your operator for today's call.

Auna S.A. (AUNA) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.03 per share a year ago.

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the second quarter ended June 30, 2025 (“second quarter 2025” or “2Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 2Q25 Consolidated Highlights Consolidat.

Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced that its common shares will begin trading on the Lima Stock Exchange (“BVL”) today. This milestone is part of the Company's strategy to improve trading liquidity, strengthen its presence in Latin America´s capital markets, and expand its access to local and regional investors. Auna's common shares are now traded on bot.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2025 financial results. Earnings Release Tuesday, August 19, 2025 Time: After Market Close Conference Call Wednesday, August 20, 2025 Time: 8:00 a.m. ET Quiet Period Monday, August 4 through Tuesday, August 19, 2025 To participate, please dial +1 888 5.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today that its controlling shareholder, Enfoca Sociedad Administradora de Fondos de Inversión S.A. (“Enfoca”), has notified the Company about the status of its sponsor-level financing. According to Enfoca, its “sponsor-level financing which had a final maturity of October 5, 2025, has been successfully refinanced. The new faci.

AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery.